How does the Hippo pathway kinase LATS1/2 (Ser909/872) regulate intestinal stem cell fate and Wnt signaling?

1. What Core Signaling Networks Interact to Maintain Intestinal Homeostasis?

The intestinal epithelium is one of the most rapidly renewing tissues in the body, and its dynamic balance strictly depends on the precise regulation of intestinal stem cells (ISCs). The self-renewal, proliferation, and differentiation of ISCs are jointly controlled by a series of complex and interconnected signaling pathways, among which the Wnt/β-catenin signaling pathway plays a dominant role as the core driver of maintaining ISC stemness and driving crypt cell proliferation. At the same time, the Hippo signaling pathway, a key pathway regulating organ size, tissue regeneration, and tumorigenesis, has garnered increasing attention for the function of its core components in the intestinal epithelium. The core kinase complex of the Hippo pathway, particularly the large tumor suppressor kinases 1 and 2 (LATS1/2), controls cell proliferation and fate determination by phosphorylating and inhibiting the activity of downstream effectors Yes-associated protein (YAP) and its homolog transcriptional coactivator with PDZ-binding motif (TAZ). However, the fine regulatory mechanisms of LATS1/2 kinases in intestinal homeostasis, especially their role in ISCs and the Wnt signaling pathway, remain incompletely understood.

2. What Impact Does LATS1/2 Kinase Deletion Have on Intestinal Stem Cells?

To clarify the function of LATS1/2 in the intestine, the research team constructed conditional knockout models. The study found that specific deletion of the Lats1/2 genes in intestinal epithelial cells led to the loss of intestinal stem cells, a phenotype consistent with impaired Wnt signaling pathway activity. However, paradoxically, the intestinal crypts exhibited significant expansion upon Lats1/2 deletion, and this expansion was independent of the canonical Wnt signaling pathway. This seemingly contradictory phenomenon suggests that LATS1/2 has a dual role in regulating intestinal homeostasis: on one hand, it is essential for maintaining ISC stemness and Wnt pathway activity; on the other hand, it may restrict abnormal crypt hyperplasia by inhibiting certain pro-proliferative signals. Thus, LATS1/2 may act as a "bidirectional regulator" of intestinal homeostasis, balancing stem cell maintenance and excessive proliferation.

3. How Does LATS1/2 Regulate Wnt Signaling and Proliferation Through Different Molecular Mechanisms?

In-depth research revealed the complexity of LATS1/2 regulation and identified the core mediating role of YAP/TAZ and their association with the transcription factor TEAD.

1. YAP/TAZ-Dependent, TEAD-Independent Wnt Signaling Inhibition: Genetic and proteomic analyses demonstrated that the inhibition of the Wnt signaling pathway after LATS1/2 deletion was entirely dependent on the activation of its downstream effectors YAP and TAZ. However, this inhibitory effect did not require the classic binding partner of YAP/TAZ—the transcriptional enhancer associate domain (TEAD) family of transcription factors. This discovery challenges the traditional notion that "YAP/TAZ activity must function through TEAD." Mechanistically, the study found that when LATS1/2 deletion led to the dephosphorylation and nuclear entry of YAP/TAZ, they interacted with the transcriptional corepressor TLE (Groucho/Transducin-Like Enhancer of Split). TLE is a corepressor of the Wnt pathway effector TCF (T-cell factor). By binding to TLE, YAP/TAZ may enhance its inhibitory capacity toward TCF-mediated transcriptional complexes, thereby blocking the expression of Wnt target genes at the transcriptional level.

2. TEAD-Dependent Pro-Proliferative Signaling Drive: On the other hand, the abnormal crypt expansion induced by LATS1/2 deletion was closely related to the activation of the YAP/TAZ-TEAD transcriptional complex. TEAD activity depends on its own palmitoylation modification. Using a novel, reversible small-molecule inhibitor to specifically block TEAD palmitoylation and thereby inhibit its transcriptional activity, researchers found that this TEAD inhibitor could significantly suppress the Wnt-independent cell proliferation and upregulation of the proto-oncogene Myc induced by Lats1/2 deletion. More importantly, in an Apc mutation model mimicking human intestinal cancer, simultaneous inhibition of LATS (simulating YAP/TAZ activation) and TEAD effectively curbed tumor overproliferation, suggesting that targeting TEAD palmitoylation is a potential strategy for intervening in related intestinal malignancies.

4. What Is the Value of the LATS1/2 (Ser909/872) Phosphorylation Antibody in Mechanistic Research?

The kinase activity of LATS1/2 is critical for its function, and its activation state can be assessed by the phosphorylation level of its key activation loop. Among these, LATS1 Ser909 and LATS2 Ser872 (or corresponding sites) are important phosphorylation sites representing its kinase activity.

Therefore, the highly specific LATS1/2 (Ser909/872) Recombinant Rabbit Monoclonal Antibody has core application value in studying the Hippo pathway and intestinal biology:

1. Precise Assessment of Hippo Pathway Activity: This antibody can be directly used to detect the activation state of LATS1/2 kinases during intestinal development, homeostasis maintenance, or under different pathological conditions (e.g., inflammation, tumors), thereby reflecting the regulatory input of upstream signals on the Hippo pathway.

2. Deciphering Signal Interaction Networks: When studying how Wnt, inflammatory, or nutritional signals affect the Hippo pathway, detecting changes in p-LATS1/2 levels can help establish regulatory connections between different signaling pathways and the core Hippo kinases.

3. Validating Genetic and Pharmacological Intervention Effects: In models with Lats gene knockout or knockdown, this antibody can confirm the loss of kinase activity. Similarly, when screening or evaluating agonists or inhibitors targeting upstream Hippo pathway components (e.g., MST1/2 kinases), p-LATS1/2 levels serve as a key pharmacodynamic readout.

5. Summary and Outlook

This study profoundly reveals the core and complex role of the Hippo pathway core kinase LATS1/2 in regulating intestinal homeostasis. It functions through two distinct mechanisms: on one hand, it maintains Wnt signaling activity and the intestinal stem cell pool by inhibiting YAP/TAZ (in a TEAD-independent manner); on the other hand, it prevents abnormal crypt hyperplasia by limiting YAP/TAZ-TEAD-mediated pro-proliferative signals. This discovery not only deepens our understanding of the signaling network in the intestinal stem cell niche but also highlights the potential of targeting TEAD palmitoylation as a new strategy for treating intestinal malignancies associated with Wnt signaling dysregulation and Hippo pathway abnormalities. In the future, leveraging tools such as the LATS1/2 (Ser909/872) Recombinant Rabbit Monoclonal Antibody to explore the dynamic changes of this pathway in different physiological and pathological contexts will facilitate the development of more precise intervention strategies.

6. Which Manufacturers Provide the LATS1/2 (Ser909/872) Recombinant Rabbit Monoclonal Antibody?

Hangzhou Starter Biotechnology Co., Ltd. has independently developed the "Phospho-LATS1/2 (Ser909/872) Recombinant Rabbit Monoclonal Antibody" (product name: Phospho-LATS1/2(Ser909/872) Recombinant Rabbit mAb (S-1874-69), catalog number: S0B1465), a high-specificity, high-sensitivity, and highly stable tool for detecting the activation state of the Hippo pathway core kinases. This product was developed using recombinant rabbit monoclonal antibody technology and has been rigorously validated across multiple platforms, including Western Blot (WB) and immunofluorescence (IF). It holds key application value in research areas such as contact inhibition, organ size control, and tumorigenesis.

Professional Technical Support: We provide comprehensive product technical documentation, including examples of phosphorylation dynamics under different cell densities or relevant stimuli, correlation analysis recommendations with downstream p-YAP (S127) detection, and specialized technical consultations, fully assisting customers in achieving precise and reliable discoveries in the fields of cell growth regulation and tumor biology.

Hangzhou Starter Biotechnology Co., Ltd. is committed to providing high-quality, high-value biological reagents and solutions for global innovative pharmaceutical companies and research institutions. For more information about the "Phospho-LATS1/2 (Ser909/872) Recombinant Rabbit Monoclonal Antibody" (catalog number S0B1465) or to request sample testing, please contact us.

Product Information